跳至主要内容
临床试验/NCT00489515
NCT00489515已完成不适用

Visceral Lymphatic Mapping Project: A Pilot Study

Wake Forest University Health Sciences1 个研究点 分布在 1 个国家目标入组 115 人开始时间: 1999年2月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
115
试验地点
1
主要终点
Ability of surgically defined sentinel lymph nodes to predict whether other lymph nodes are involved with the tumor

研究概览

简要总结

RATIONALE: Diagnostic procedures, such as visceral lymphatic mapping using isosulfan blue, may help find cancer of the pancreas, colon, stomach, small intestine, or gallbladder and find out how far the disease has spread.

PURPOSE: This clinical trial is studying the side effects and how well visceral lymphatic mapping using isosulfan blue works in patients with cancer of the pancreas, colon, stomach, small intestine, or gallbladder.

详细描述

OBJECTIVES:

Primary

  • Evaluate the safety and feasibility of visceral lymphatic mapping using isosulfan blue in patients with adenocarcinoma of the pancreas, colon, stomach, small bowel, or gallbladder.
  • Evaluate the ability of surgically defined sentinel lymph nodes to predict whether other lymph nodes in the basin are involved with the tumor in these patients.

Secondary

  • Compare the results obtained from the sentinel lymph node (i.e., positive or negative for metastatic disease) with the results obtained from the other nodes in these patients.
  • Compare immunohistochemical analysis with standard analysis of the sentinel lymph nodes in these patients.
  • Evaluate the value of intraoperative touch prep analysis of sentinel lymph nodes in these patients.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Ability of surgically defined sentinel lymph nodes to predict whether other lymph nodes are involved with the tumor

时间窗: 1 week

Safety, as determined by the number of adverse events resulting from procedure

时间窗: 1 week

Safety will be assessed by documenting the number of adverse clinical events resulting from the procedure

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验